News | Artificial Intelligence | February 16, 2024

Cardio Diagnostics Holdings, Inc. Expands HeartRisk Platform Offering to Diverse Markets in Conjunction with Nationwide Rollout

Transformative cardiovascular risk management solutions extend beyond traditional sectors to include federal and state correctional facilities, broker and benefits organizations, and risk bearing providers

Transformative cardiovascular risk management solutions extend beyond traditional sectors to include federal and state correctional facilities, broker and benefits organizations, and risk bearing providers

February 16, 2024 — Cardio Diagnostics Holdings, Inc., an AI-driven precision cardiovascular medicine company, announced the nationwide rollout and a significant expansion of its groundbreaking HeartRisk platform. HeartRisk combines insights from HIPAA-compliant anonymized and aggregated clinical cardiovascular data obtained through Cardio Diagnostics’ Epi+Gen CHD and PrecisionCHD clinical tests, with industry and geographic data to enable real-time population-level cardiovascular disease (CVD) risk insights.

This expansion extends the reach of its proprietary data intelligence platform to correctional facilities, risk-bearing providers engaged in value-based contracts, and broker and benefits consultants. The move marks a strategic leap in addressing the financial and security challenges, such as those associated with transporting inmates in correctional facilities, of scaling access to cardiovascular testing across diverse sectors.

"By expanding our HeartRisk platform, we're not just innovating within traditional healthcare sectors but breaking new ground in diverse markets. From correctional facilities to value-based care providers and workplace wellness programs to brokerage and benefits consultants, our precision cardiovascular solutions provide actionable insights. By coupling data intelligence to evidence-based and scalable clinical tests, we're enabling these healthcare stakeholders and their organizations to make data-driven decisions to address rising healthcare costs and implement more effective chronic disease management. We're not just advancing precision medicine; we're ensuring those insights can be leveraged at the population level for multiple sectors," shared Meesha Dogan, Ph.D., CEO and Co-Founder of Cardio Diagnostics.

Risk-Bearing Providers and Value-Based Care

Risk-bearing providers, such as Family Medicine Specialists that receive monthly HeartRisk population data, can better manage their shared-risk and value-based contracts by identifying and stratifying at-risk populations, and understanding the drivers of heart disease, ensuring quality measures and ratings are met. This leads to benefiting from shared risk contracts while better-managing patient health.

Family Medicine Specialists' implementation of Cardio Diagnostics' tests in their patient population with CHD risk factors demonstrates the first time a risk-bearing provider is leveraging precision epigenetics-based heart disease technologies with a population health intelligence tool to optimize risk-sharing contracts. HeartRisk's ability to aggregate population-level heart attack risk, the presence of heart disease detection, and intervention monitoring and management aligns with the financial incentives of shared-risk contracts.

Empowering Workplace Wellness & Financial Health

The expanded offering equips employers with unparalleled insights into workforce health trends related not just to cardiovascular risks but also encapsulating broader wellness indicators crucial for business resilience and productivity. By integrating predictive analytics around CVD within comprehensive workplace wellness initiatives, employers can reduce healthcare costs significantly while fostering an invigorated workplace culture centered on health mindfulness.

Enabling Precision-Driven Decision-Making for Employer Clients

Brokerage and benefits entities play a pivotal role in aligning coverage plans that articulate both value and efficacy against chronic conditions like CVD, which are substantial cost centers for their clientele. The enhanced functionalities within the HeartRisk platform allow these entities to offer meticulous plan designs optimized by granular cumulative data insights, thus ensuring impactful investments in healthcare portfolios. This includes being able to guide employer clients on stop-loss insurance decisions, benefits allocations, and premium and escrow limits using more real-time aggregated employer CVD risk intelligence data based on clinical tests for a prospective analysis rather than a retrospective analysis.

Tackling Healthcare Challenges Behind Bars: A Constitutional Requirement

Cardiovascular disease is a leading cause of death among incarcerated individuals. The incarcerated population exhibits higher rates of cardiovascular risk factors, such as smoking and hypertension, compared to the general population. Correctional facilities have a constitutional obligation to care for the health of incarcerated individuals. This includes the provision of medical and mental health care, which is complicated by the high prevalence of chronic diseases, mental health issues, and substance use disorders among the incarcerated population.

The complexity of providing care in correctional facilities is exacerbated by resource constraints and the difficulty of providing specialized care for heart disease without transportation. The costs and security risks associated with transporting inmates into healthcare settings and facilities are staggering. Annually, more than $90 million is spent on transporting inmates to U.S Hospitals annually. HeartRisk, driven by the adoption of Epi+Gen CHD and PrecisionCHD via telehealth, is a highly scalable approach for correctional facilities to obtain heart attack and heart disease insights.

Impact on Healthcare Costs and Chronic Disease Management

The expansion of the HeartRisk platform is aligned with the broader trend in healthcare towards prevention and value-based care. Preventive measures are not only lifesaving but also economically beneficial, with an estimated return of $6.30 in savings for every $1 invested. Active strategies for risk factor reduction, prevention, and treatment of CVD, powered by precision population analytics, are key to addressing these growing cardiovascular cost challenges.

For more information: www.cardiodiagnosticsinc.com

 


Related Content

Feature | Information Technology | By Melinda Taschetta-Millane

​The Healthcare Information and Management Systems Society (HIMSS) Global Health Conference and Exhibition brought ...

Home May 01, 2024
Home
Feature | Information Technology

Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...

Home March 21, 2024
Home
News | Information Technology

March 7, 2024 — Siemens Healthineers has launched an app designed for Apple Vision Pro that enables users such as ...

Home March 07, 2024
Home
News | Information Technology

November 14, 2023 — To help provide clinicians a comprehensive workflow, GE HealthCare is working towards the seamless ...

Home November 14, 2023
Home
Feature | Information Technology | By Melinda Taschetta-Millane

Healthcare is constantly evolving, finding new ways to innovate and advance digital tools and technology. With this ...

Home July 14, 2023
Home
Videos | Information Technology

HIMMS is working to bring empirical knowledge and evidence of value and impact of digital maturity measured by the HIMSS ...

Home May 17, 2023
Home
Videos | Information Technology

Healthcare is constantly evolving, finding new ways to innovate and advance digital tools and technology. With this ...

Home May 11, 2023
Home
Feature | Information Technology

Many cardiology departments face significant challenges meeting regulatory requirements, quality metrics, and ...

Home February 10, 2023
Home
Case Study | Information Technology

This case study from Change Healthcare presents the following: Customer: Washington Health System Washington, PA ...

Home January 10, 2023
Home
News | Information Technology

February 24, 2022 — Imagine that you are admitted to hospital. A smart scheduling system ensures you have a bed; you ...

Home February 24, 2022
Home
Subscribe Now